Hodgkin's Disease in Patients Infected with Human Immunodeficiency Virus: Frequency, Presentation and Clinical Outcome

References

• Reynolds P, Saunders L D, Layefsky M E, Lemp G F. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980–1987. American Journal of Epidemiology 1993; 137: 19–30
   PubMed Web of Science ®Google Scholar
• Hessol N A, Katz M H, Liu J Y, Buchbinder S P, Rubino C J, Holmberg S D. Increased incidence of Hodgkin disease in homosexual men with HIV infection [see comments]. Annals of Internal Medicine 1992; 117: 309–311
   PubMed Web of Science ®Google Scholar
• Biggar R J, Horm J, Lubin J H, Goedert J J, Greene M H, Fraumeni J F, Jr. Cancer trends in a population at risk of acquired immunodeficiency syndrome. Journal of the National Cancer Institute 1985; 74: 793–797
   PubMed Web of Science ®Google Scholar
• Bernstein L, Levin D, Menck H, Ross R K. AIDS-related secular trends in cancer in Los Angeles County men: a comparison by marital status. Cancer Research 1989; 49: 466–470
   PubMed Web of Science ®Google Scholar
• Scadden D. AIDS-related lymphomas. Hematology: basic principles and practiceed 3rd. Churchill Livingstone. 2000
   Google Scholar
• control Cfd. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: 1S–15S
   Google Scholar
• control Cfd. Revision of the case definition of aqcuired immunodeficiency syndrome for national reporting United States. MMWR 1985; 34: 373–335
   PubMedGoogle Scholar
• Tirelli U, Serraino D, Carbone A. Hodgkin disease and HIV [letter; comment]. Annals of Internal Medicine 1993; 118: 313, discussion 313–314
   PubMedGoogle Scholar
• Kaplan L. AIDS-associated lymphomas. Inf Dis Clin N Am 1988; 2: 525
   PubMedGoogle Scholar
• Carbone A, Tirelli U, Vaccher E, Volpe R, Gloghini A, Bertola G, De Re V, Rossi C, Boiocchi M, Monfardini S. A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy. Cancer 1991; 68: 842–852
   PubMed Web of Science ®Google Scholar
• Ames E, Conjalka M, Goldberg A. Hodgkin's disease in homosexual men with generalized lymphadenopathy. Hematol Oncol Clin N Am 1991; 5: 343
   PubMedGoogle Scholar
• Schoeppel S L, Hoppe R T, Dorfman R F, Homing S J, Collier A C, Chew T G, Weiss L M. Hodgkin's disease in homosexual men with generalized lymphadenopathy. Annals of Internal Medicine 1985; 102: 68–70
   PubMed Web of Science ®Google Scholar
• Monfardini S, Tirelli U, Vaccher E, Foa R, Gavosto F. Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). Annals of Oncology 1991; 2: 201–205
   PubMed Web of Science ®Google Scholar
• Lowenthal D A, Straus D J, Campbell S W, Gold J W, Clarkson B D, Koziner B. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988; 61: 2325–2337
   PubMed Web of Science ®Google Scholar
• Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, Franceschi S, Boiocchi M, Carbone A. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. Journal of Clinical Oncology 1995; 13: 1758–1767
   PubMed Web of Science ®Google Scholar
• Levine A. Biological and clinical aspects. Hematol Oncol Clin N Am 1996; 10: 1135
   PubMed Web of Science ®Google Scholar
• Bellas C, Santon A, Manzanal A, Campo E, Martin C, Acevedo A, Varona C, Forteza J, Morente M, Montalban C. Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection. Comparison with ordinary hodgkin's disease. American Journal of Surgical Pathology 1996; 20: 1520–1524
   PubMed Web of Science ®Google Scholar
• De Vita V TJ, Hellman S, Jaffe E S. Hodgkin's disease. Cancer, Principles & Practice of Oncologyed Fourth, V TJ De Vita, S Hellman, S A Rosenberg. J. B. Lippincott Company, Philadelphia 1993; Vol. 2: 1819–1858
   Google Scholar
• Rubio R. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 1994; 73: 2400–2407
   PubMed Web of Science ®Google Scholar
• Ree H J, Strauchen J A, Khan A A, Gold J E, Crowley J P, Kahn H, Zalusky R. Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells [see comments]. Cancer 1991; 67: 1614–1621
   PubMed Web of Science ®Google Scholar
• Tirelli U, Carbone A, Straus D. Hodgkin's disease. P Mauch, J Armitage, V Diehl, R Hoppe, L Weiss. Lippincott Williams and Wilkins, Philadelphia 1999
   Google Scholar
• Carbone P P, Kaplan H S, Musshoff K, Smithers D W, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. J Amer Statistical Assoc 1958; 53: 257–481
   Google Scholar
• Hagemeister F, McLaughlin P, Velasquez W, Riggs S, Salvador P, Cabanillas F. CVPP-ABDIC alternating chemotherapy for advanced Hodgkin's disease (HD). ASCO; 1985; 4: 212
   Google Scholar
• Bonnadona G, Zucali R, Monfardini S, De Lena M, Uslenghi C. Combination chemotherapy of Hodgkin's disease with Adriamycin, bleomycin, cinblastine and imidazole carboxamide versus MOPP. Cancer 1975; 36: 252–259
   PubMed Web of Science ®Google Scholar
• Preti A, Hagemeister F B, McLaughlin P, Swan F, Rodriguez A, Besa P, Cox J D, Allen P K, Cabanillas F. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches. Annals of Oncology 1994; 5: 97–100, Suppl
   PubMed Web of Science ®Google Scholar
• Hagemeister F B, Purugganan R, Fuller L, McLaughlin P, Swan F, Jr, Romaguera J, Rodriguez M, Cabanillas F. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy. Semin Hematol 1994; 31: 36–43
   PubMed Web of Science ®Google Scholar
• Goedert J J, Cote T R, Virgo P, Scoppa S M, Kingma D W, Gail M H, Jaffe E S, Biggar R J. Spectrum of AIDS-associated malignant disorders [see comments]. Lancet 1998; 351: 1833–1839
   PubMed Web of Science ®Google Scholar
• Roithman S, Tourani J, Gastaut J, Brice P, Raphael M, Dujardin P, Desablens B, Andrieu J. Maladie de Hodgkin's survenant au cours de l'infection a VIH: characteristiques cliniques et evolution. Bull Cancer 1992; 79: 873–882
   PubMedGoogle Scholar
• Knowles D M, Chamulak G A, Subar M, Burke J S, Dugan M, Wernz J, Slywotzky C, Pelicci G, Dalla-Favera R, Raphael B. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981–1986). Annals of Internal Medicine 1988; 108: 744–753
   PubMed Web of Science ®Google Scholar
• Roithmann S, Andrieu J M. Clinical and biological characteristics of malignant lymphomas in HIV-infected patients. European Journal of Cancer 1992; 28A: 1501–1508
   PubMed Web of Science ®Google Scholar
• Andrieu J M, Roithmann S, Tourani J M, Levy R, Desablens B, le Maignan C, Gastaut J A, Brice P, Raphael M, Taillan B. Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors. Annals of Oncology 1993; 4: 635–641
   PubMed Web of Science ®Google Scholar
• Errante D, Gabarre J, Ridolfo A, Rossi G, Nosari A, Gisselbrecht C, Kerneis Y, Mazzetti F, Vaccherm E, Talamini R, Carbone A, Tirelli U. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vincristine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Annals of Oncology 1999; 10: 189–195
   PubMed Web of Science ®Google Scholar
• Tirelli U, Errante D, Santarossa S, Spina M, Giddelbrecht C, Marolleau P, Kerneis Y, Ridolfo A, Bottura P, Pan A PDF, Rossi G, Tavio M. Epirubicin, bleomycin, vinblastine, and prednizone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF for patients with antiretroviral therapy and HIV infection. J AIDS and Human Retroviral 1997; 14: A32
   Google Scholar
• Levine A, Cheung T, Tulpule A, Huang J, Testa M. Preliminary results of AIDS Clinical Trial Groups (ACTG) study #149: phase II trial of ABVD chemotherapy with G-CSF in HIV-infected patients with Hodgkin's disease. J AIDS Human Retroviral 1997; 14: A12
   Google Scholar
• Gold J E, Altarac D, Ree H J, Khan A, Sordillo P P, Zalusky R. HIV-associated Hodgkin disease: a clinical study of 18 cases and review of the literature. American Journal of Hematology 1991; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Kuppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann M L. Hodgkin's and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin rearrangements and appear to be derived from V cells at various stages of development. Proc Natl Acad Sci USA 1994; 91: 10962–10966
   PubMed Web of Science ®Google Scholar
• Liu Y J, Mason D Y, Johnson G D, Abbot S, Gregory C D, Hardie D L, Gordon J, MacLennan I C. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. European Journal of Immunology 1991; 21: 1905–1910
   PubMed Web of Science ®Google Scholar
• Marafioti T, Hummel M, Foss H D, Laumen H, Korbjuhn P, Anagnostopoulos I, Lammert H, Demel G, Theil J, Wirth T, Stein H. Hodgkin's and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443–1450
   PubMed Web of Science ®Google Scholar
• Carbone A, Gloghini A, Larocca L M, Antinori A, Falini B, Tirelli U, Dalla-Favera R, Gaidano G. Human Immunodeficiency Virus-Associated Hodgkin's disease derives from post-germinal center B-cells. Blood 1999; 93: 2319–2326
   PubMed Web of Science ®Google Scholar
• Gregory C D, Dive C, Henderson S, Smith C A, Williams G T, Gordon J, Rickinson A B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991; 349: 612–614
   PubMed Web of Science ®Google Scholar
• Sarris A H, Medeiros L J, Herling M, Khorana S, Kliche K O, Mesina O, Hagemeister F B, Romaguera J, McLaughlin P, Preti H A, Rodriguez M A, Andreeff M, Cabanillas F. The Expression of the EBV-Coded Latent Membrane Protein-1 (LMP-1) In Reed-Sternberg Cells Of Hodgkin's Disease (HD) Is Associated With Higher Serum IL-10 Levels And Inferior Failure-Free Survival (FFS). Blood 1998; 92(Suppl 1)353a
   PubMed Web of Science ®Google Scholar
• Siebert J D, Ambinder R F, Napoli V M, Quintanilla-Martinez L, Banks P M, Gulley M L. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus [see comments]. Human Pathology 1995; 26: 1191–1195
   PubMed Web of Science ®Google Scholar
• Uccini S, Monardo F, Ruco L P, Baroni C D, Faggioni A, Agliano A M, Gradilone A, Manzari V, Vago L, Costanzi G, et al. High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease [letter]. Lancet 1989; 1: 1458
   PubMed Web of Science ®Google Scholar
• Moran C A, Tuur S, Angritt P, Reid A H, O'Leary T J. Epstein-Barr virus in Hodgkin's disease from patients with human immunodeficiency virus infection. Modern Pathology 1992; 5: 85–88
   PubMed Web of Science ®Google Scholar
• Audouin J, Diebold J, Pallesen G. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. Journal of Pathology 1992; 167: 381–384
   PubMed Web of Science ®Google Scholar
• Sarris A H, Medeiros L M, Khorana S, Herling M, Viviani S, Bonfante V, Giardini R, Hagemeister F B, Romaguera J, McLaughlin P, Preti A, Rodriguez M A, Notti P, Ford R, Bonadonna G, Cabanillas F. Bcl-2 Is Frequently Expressed In Hodgkin-Reed-Sternberg Cells And Is Associated With Inferior Failure-Free Survival In Hodgkin's Disease Treated With ABVD. Annals of Oncology 1999; 10(Suppl 3)72
   Google Scholar
• Sarris A HOKK, Pethambaram P, Preti A, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister F B, McLaughlin P, Rodriguez M A, Romaguera J, Fritsche H, Duvic M, Andreeff M, Cabanillas F. Interleukin-10 Levels are Often Elevated In Serum of Adults With Hodgkin's Disease and are Associated with Inferior Failure-Free Survival. Annals of Oncology 1999; 10: 1–8
   Web of Science ®Google Scholar
• Viviani S, Notti P, Bonfante V, Verderio P, Valagussa P, Bonadonna G. Elevated pretreatment serum levels of 11–10 are associated with a poor prognosis in Hodgkin's Disease, the Milan Cancer Institute Experience. Medical Oncology 1999; 16: 1–5
   Web of Science ®Google Scholar
• Stylianou E, Aukrust P, Kvale D, Muller F, Froland S S. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression—down-regulatory effect of potent anti-retroviral therapy. Clinical & Experimental Immunology 1999; 116: 115–120
   PubMed Web of Science ®Google Scholar
• Masood R, Zhang Y, Bond M W, Scadden D T, Moudgil T, Law R E, Kaplan M H, Jung B, Espina B M, Lunardi-Iskandar Y, Levine A M, Gill P S. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related-B-cell lymphoma. Blood 1995; 85: 3423–3430
   PubMed Web of Science ®Google Scholar
• Ng V L, Hurt M H, Fein C L, Khayam-Bashi F, Marsh J, Nunes W M, McPhaul L W, Feigal E, Nelson P, Herndier B G. IgMs produced by two acquired immune deficiency syndrome lymphoma cell lines: Ig binding specificity and VH-gene putative somatic mutation analysis. Blood 1994; 83: 1067–1078
   PubMed Web of Science ®Google Scholar
• Riboldi P, Gaidano G, Schettino E W, Steger T G, Knowles S M, Dalla-Favera R, Casali P. Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-IgM cold agglutinins using somatically mutated VH4–21 segments. Blood 1994; 83: 2952–2961
   PubMed Web of Science ®Google Scholar
• Bessudo A, Cherepakhin B, Johnson T A, Rassenti L Z, Feigal E, Kipps T J. Favored use of immunoglobulin VH4 genes in AGDS-associated B-cell lymphomas. Blood 1996; 88: 252–260
   PubMed Web of Science ®Google Scholar
• Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. Journal of Clinical Oncology 1993; 1993: 1674–1681
   Google Scholar
• Hamilton-Dutoit S J, Pallesen G, Franzmann M B, Karkov J, Black F, Skinho J, Pedersen C. AIDS-related lymphoma: histopathology, immunopenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. American Journal of Pathology 1991; 138: 149–163
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S J, Rea D, Raphael M, Sandvej K, Delecluse H J, Gisselbrecht C, Marelle L, van Krieken H J, Pallesen G. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 1993; 143: 1072–1085
   PubMed Web of Science ®Google Scholar